Red Nucleus Acquires COEUS

Red Nucleus Acquires Bridge Medical Consulting

February 5, 2026

Healthcare Services

Red Nucleus has acquired Bridge Medical Consulting, a UK-based health economics and outcomes research (HEOR) consultancy, to broaden its HEOR, real-world evidence, and market access capabilities for biopharmaceutical clients. The firm will be merged into Red Nucleus's existing HEOR business to expand evidence synthesis, economic modeling, RWE research, and AI-enabled workflows.

Red Nucleus Acquires Jupiter Life Science Consulting

September 12, 2022

Consulting

Red Nucleus, a Riverside-backed life sciences services platform, has acquired Jupiter Life Science Consulting, a boutique provider of market access and commercialization strategies for pharma, biotech, and medical device clients. The add-on expands Red Nucleus's commercial and market-access capabilities, bringing Jupiter's expertise in payer research, pricing and access strategy, and commercialization planning into the combined platform.

The Riverside Company Acquires Red Nucleus from Renovus Capital Partners

March 24, 2020

Education

The Riverside Company has acquired Red Nucleus Enterprises, LLC, a Yardley, Pennsylvania-based provider of digital learning and regulatory compliance services for the life sciences industry. Renovus Capital Partners sold the company to Riverside but retained a minority equity stake and will continue to support future growth; Riverside plans to expand Red Nucleus's training offerings, technology capabilities and pursue add-on acquisitions.

COEUS Holdings Acquires Afore, LLC

September 27, 2021

Healthcare Services

COEUS Holdings has acquired Afore, a New Jersey–based life sciences consulting firm that provides commercial technology solutions, software integration, and data services. The purchase will integrate Afore into COEUS Solutions to expand COEUS' technology capabilities for pharmaceutical and biotech clients; Afore founder James Corbett will serve as COO of COEUS Solutions.

THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company

October 17, 2024

Healthcare Services

THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.

CoreRx Acquires Nucleo Life Sciences

May 24, 2021

Pharmaceuticals

CoreRx, Inc. has acquired Nucleo Life Sciences, a boutique CDMO based in San Rafael, California, expanding CoreRx’s US West Coast development presence and formulation capabilities. The deal, supported by CoreRx’s majority owner NovaQuest Private Equity and other shareholders, will integrate Nucleo’s Fast-to-Clinic formulation expertise (including spray-dried dispersions and NucleLoad) into CoreRx’s development and manufacturing platform.